Delineating inflammatory bowel disease through transcriptomic studies: current review of progress and evidence

다국어 초록 (Multilingual Abstract)

Inflammatory bowel disease (IBD), which comprises of Crohn’s disease and ulcerative colitis, is an idiopathic relapsing and remitting disease in which the interplay of different environment, microbial, immunological and genetic factors that attribute to the progression of the disease. Numerous studies have been conducted in multiple aspects including clinical, endoscopy and histopathology for the diagnostics and treatment of IBD. However, the molecular mechanism underlying the aetiology and pathogenesis of IBD is still poorly understood. This review tries to critically assess the scientific evidence at the transcriptomic level as it would help in the discovery of RNA molecules in tissues or serum between the healthy and diseased or different IBD subtypes. These molecular signatures could potentially serve as a reliable diagnostic or prognostic biomarker. Researchers have also embarked on the study of transcriptome to be utilized in targeted therapy. We focus on the evaluation and discussion related to the publications reporting the different approaches and techniques used in investigating the transcriptomic changes in IBD with the intention to offer new perspectives to the landscape of the disease.

참고문헌 (Reference)

1 Thompson DM, "tRNA cleavage is a conserved response to oxidative stress in eukaryotes" 14 : 2095-2103, 2008

2 Coskun M, "miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis" 19 : 4289-4299, 2013

3 Wan Y, "Understanding the transcriptome through RNA structure" 12 : 641-655, 2011

4 Hasler R, "Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease" 66 : 2087-2097, 2017

5 Mirza AH, "Transcriptomic landscape of lncRNAs in inflammatory bowel disease" 7 : 39-, 2015

6 Adams J, "Transcriptome: connecting the genome to gene function" 1 : 195-, 2008

7 Cardinale CJ, "Transcriptome profiling of human ulcerative colitis mucosa reveals altered expression of pathways enriched in genetic susceptibility loci" 9 : e96153-, 2014

8 Schanen BC, "Transcriptional regulation of mammalian miRNA genes" 97 : 1-6, 2011

9 Lee TI, "Transcriptional regulation and its misregulation in disease" 152 : 1237-1251, 2013

10 Planell N, "Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations" 62 : 967-976, 2013

11 Mathew S, "The need behind messenger RNA sequencing analysis" 3 : 1260-1270, 2015

12 Mercer TR, "The human mitochondrial transcriptome" 146 : 645-658, 2011

13 Frith MC, "The amazing complexity of the human transcriptome" 13 : 894-897, 2005

14 Raja Affendi Raja Ali, "The Positive Influences of Increasing Age at Diagnosis of Inflammatory Bowel Disease on Disease Prognostication in Asian Perspective" 대한장연구학회 13 (13): 4-5, 2015

15 Palmieri O, "Systematic analysis of circadian genes using genome-wide cDNA microarrays in the inflammatory bowel disease transcriptome" 32 : 903-916, 2015

16 Giege R, "Structure of transfer RNAs: similarity and variability" 3 : 37-61, 2012

17 Swanson GR, "Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?" 7 : 29-36, 2011

18 Torres AG, "Role of tRNA modifications in human diseases" 20 : 306-314, 2014

19 Novikova IV, "Rise of the RNA machines: exploring the structure of long non-coding RNAs" 425 : 3731-3746, 2013

20 Karahan G, "Relative expression of rRNA transcripts and 45S rDNA promoter methylation status are dysregulated in tumors in comparison with matched-normal tissues in breast cancer" 33 : 3131-3145, 2015

21 Fabian MR, "Regulation of mRNA translation and stability by microRNAs" 79 : 351-379, 2010

22 Muers M, "RNA: genome-wide views of long non-coding RNAs" 12 : 742-, 2011

23 Hong SN, "RNA-seq reveals transcriptomic differences in inflamed and noninflamed intestinal mucosa of Crohn's disease patients compared with normal mucosa of healthy controls" 23 : 1098-1108, 2017

24 Wang Z, "RNA-Seq: a revolutionary tool for transcriptomics" 10 : 57-63, 2009

25 Richard H, "Prediction of alternative isoforms from exon expression levels in RNA-Seq experiments" 38 : e112-, 2010

26 Gray NK, "Poly(A)-binding proteins and mRNA localization: who rules the roost?" 43 : 1277-1284, 2015

27 Porokhovnik LN, "Oxidative stress, rRNA genes, and antioxidant enzymes in pathogenesis of schizophrenia and autism: modeling and clinical advices" 74 : 340-353, 2013

28 Melancon CE 3rd, "One plasmid selection system for the rapid evolution of aminoacyl-tRNA synthetases" 19 : 3845-3847, 2009

29 Peng GH, "Mitochondrial 12S rRNA variants studies in 456 subjects with hearing loss in seven schools for deaf and mutes in Zhejiang province" 47 : 996-1003, 2012

30 Bartel DP, "MicroRNAs: target recognition and regulatory functions" 136 : 215-233, 2009

31 Lages E, "MicroRNAs: molecular features and role in cancer" 17 : 2508-2540, 2012

32 Luningschror P, "MicroRNAs in pluripotency, reprogramming and cell fate induction" 1833 : 1894-1903, 2013

33 Pekow JR, "MicroRNAs in inflammatory bowel disease" 18 : 187-193, 2012

34 Di Stefano V, "MicroRNAs as peripheral blood biomarkers of cardiovascular disease" 55 : 111-118, 2011

35 Polytarchou C, "MicroRNA214 Is associated with progression of ulcerative colitis, and inhibition reduces development of colitis and colitis-associated cancer in mice" 149 : 981-992, 2015

36 Olaru AV, "MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease" 19 : 471-480, 2013

37 Kim HY, "MicroRNA-132 and microRNA-223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease" 31 : 1727-1735, 2016

38 Tijsen AJ, "MiR423-5p as a circulating biomarker for heart failure" 106 : 1035-1039, 2010

39 Peet A, "Marks' basic medical biochemistry (Lieberman, Marks's basic medical biochemistry)" Lippincott Williams & Wilkins 2013

40 Lander ES, "Initial sequencing and analysis of the human genome" 409 : 860-921, 2001

41 Li E, "Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition" 7 : e26284-, 2012

42 Zhang YZ, "Inflammatory bowel disease: pathogenesis" 20 : 91-99, 2014

43 Fiocchi C, "Inflammatory bowel disease: etiology and pathogenesis" 115 : 182-205, 1998

44 Prideaux L, "Inflammatory bowel disease in Asia: a systematic review" 27 : 1266-1280, 2012

45 Abraham C, "Inflammatory bowel disease" 361 : 2066-2078, 2009

46 Kaser A, "Inflammatory bowel disease" 28 : 573-621, 2010

47 Pin-Jin Hu, "Inflammatory Bowel Disease in Asia: The Challenges and Opportunities" 대한장연구학회 13 (13): 188-190, 2015

48 Ng SC, "Incidence and phenotype of inflammatory bowel disease based on results from the Asiapacific Crohn's and colitis epidemiology study" 145 : 158-165, 2013

49 Elliott DJ, "Illuminating the transcriptome through the genome" 5 : 235-253, 2014

50 Holgersen K, "High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis" 9 : 492-506, 2015

51 Cheon JH, "Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives" 28 : 220-226, 2013

52 Kornienko AE, "Gene regulation by the act of long non-coding RNA transcription" 11 : 59-, 2013

53 van Lierop PP, "Gene expression analysis of peripheral cells for subclassification of pediatric inflammatory bowel disease in remission" 8 : e79549-, 2013

54 Xu L, "Gene expression alterations in inflamed and unaffected colon mucosa from patients with mild inflammatory bowel disease" 13 : 2729-2735, 2016

55 Soderman J, "Gene Expression-genotype analysis implicates GSDMA, GSDMB, and LRRC3C as contributors to inflammatory bowel disease susceptibility" 2015 : 834805-, 2015

56 Palmieri O, "Functional implications of microRNAs in Crohn's disease revealed by integrating microRNA and messenger RNA expression profiling" 18 : E1580-, 2017

57 Saeidnia S, "From in vitro experiments to in vivo and clinical studies; pros and cons" 12 : 218-224, 2015

58 Zhao Z, "Extracellular elevation of adrenomedullin, a gene associated with schizophrenia, suppresses heat shock protein 1A/1B mRNA" 27 : 1312-1316, 2016

59 Shoemaker DD, "Experimental annotation of the human genome using microarray technology" 409 : 922-927, 2001

60 Ng SC, "Epidemiology of inflammatory bowel disease: focus on Asia" 28 : 363-372, 2014

61 Ananthakrishnan AN, "Epidemiology and risk factors for IBD" 12 : 205-217, 2015

62 Ng SC, "Emerging trends of inflammatory bowel disease in Asia" 12 : 193-196, 2016

63 Ng SC, "Emerging leadership lecture: inflammatory bowel disease in Asia: emergence of a Western disease" 30 : 440-445, 2015

64 Xu XR, "Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease" 20 : 3255-3264, 2014

65 Wu F, "Divergent influence of microRNA-21 deletion on murine colitis phenotypes" 20 : 1972-1985, 2014

66 Costello CM, "Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays" 2 : e199-, 2005

67 Chen Y, "Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis" 67 : 976-983, 2007

68 Kanaan Z, "Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer" 33 : 551-560, 2012

69 Takanori Kanai, "Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods" 대한내과학회 29 (29): 409-415, 2014

70 Bassett AR, "Considerations when investigating lncRNA function in vivo" 3 : e03058-, 2014

71 Fang K, "Application of comparative transcriptional genomics to identify molecular targets for pediatric IBD" 6 : 165-, 2015

72 Zhang T, "An ileal Crohn's disease gene signature based on whole human genome expression profiles of disease unaffected ileal mucosal biopsies" 7 : e37139-, 2012